The study group received chemotherapy ( cisplatin , gemcitabine , paclitaxel , and pemetrexed ) under the guidance of molecular markers ( excision repair cross-complementing @ ERCC@ , ribonucleotide reductase M@ RRM@ , Class III beta-tubulin , thymidylate synthetase TS ) .